Trends in the incidence of use of noninsulin glucose ‐lowering drugs between 2006 and 2013 in France
In conclusion, after reaching a peak in 2010, the incidence of use of NIGLDs has markedly decreased in France. Since then, prescribers seem to have reverted to older and well‐known therapies.
Source: Fundamental and Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Mickael Arnaud, Julien Bezin, Bernard B égaud, Antoine Pariente, Francesco Salvo Tags: Original Article Source Type: research
More News: Databases & Libraries | Drugs & Pharmacology | Fortamet | France Health | Insurance | Metformin | Study